We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

MPH Health Care AG (93M1) NPV

Sell:€21.10 Buy:€21.90 Change: €0.30 (1.45%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:€21.10
Buy:€21.90
Change: €0.30 (1.45%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:€21.10
Buy:€21.90
Change: €0.30 (1.45%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

MPH Health Care AG, formarly MPH Mittelstaendische Pharma Holding AG, is a Germany-based pharmaceuticals and investment company. The Company focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The Company's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.

Contact details

Address:
Gruenauer Strasse 5
BERLIN
12557
Germany
Telephone:
+49 (30) 863214560
Website:
https://www.mph-ag.de/en/start/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
93M1
ISIN:
DE000A289V03
Market cap:
€91.19 million
Shares in issue:
4.28 million
Sector:
Pharmaceuticals
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Andrea Grosse
    Chairwoman of the Supervisory Board
  • Uwe Zimdars
    Deputy Chairman of the Supervisory Board
  • Patrick Brenske
    Sole Member of the Management Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.